For Alzheimer patients there is a good news. The gene variant can reduce Alzheimer disease to a large extent. The combination of two copies of cholesteryl ester transfer protein (CETP) variant, rather than the normal versions of the genes can result into a drastic reduction of chance of Alzheimer disease. These gene variants have many benefits such as to help to promote a healthy heart and also prevent memory loss.
According to recent data, around 26 million people all over the world has been suffering from the Alzheimer disease. The disease causes a rapid memory loss known as dementia and researchers continually researching to find the cause behind the memory debilitating disease, the treatments and preventative measures. Dr. Richard Lipton of the Albert Einstein College of Medicine at Yeshiva University in New York recently released a study in the Journal of the American Medical Association that researched for a gene that prevent the disease. In addition, the gene can enhance the brain memory capacity throughout the aging process.
Dr. Lipton based his study on data gathered during the 2003 Einstein Aging Study which involved elderly Bronx residents. For Lipton’s research, data was gathered from 523 individuals over 70 years old, for an average of four years. Blood samples of the participants were evaluated to determine if they carried the CETP gene variant and their mental capabilities were evaluated annually.
The study found that the subjects who carried both the copies of gene variants were endured to memory loss due to aging.
Dr. Lipton said that the gene variants could reduce the risk of Alzheimer disease by protecting the blood vessels and consequently, it prevents the risk of heart attacks and strokes. He pointed out that the strokes were the main reasons for cognitive decline. So it actually protects the brain against atherosclerotic disease.
The Alzheimer disease is expected to rise over 100 million by 2050 and researchers from all over the world trying to find an effective treatment against the disease.
According to recent data, around 26 million people all over the world has been suffering from the Alzheimer disease. The disease causes a rapid memory loss known as dementia and researchers continually researching to find the cause behind the memory debilitating disease, the treatments and preventative measures. Dr. Richard Lipton of the Albert Einstein College of Medicine at Yeshiva University in New York recently released a study in the Journal of the American Medical Association that researched for a gene that prevent the disease. In addition, the gene can enhance the brain memory capacity throughout the aging process.
Dr. Lipton based his study on data gathered during the 2003 Einstein Aging Study which involved elderly Bronx residents. For Lipton’s research, data was gathered from 523 individuals over 70 years old, for an average of four years. Blood samples of the participants were evaluated to determine if they carried the CETP gene variant and their mental capabilities were evaluated annually.
The study found that the subjects who carried both the copies of gene variants were endured to memory loss due to aging.
Dr. Lipton said that the gene variants could reduce the risk of Alzheimer disease by protecting the blood vessels and consequently, it prevents the risk of heart attacks and strokes. He pointed out that the strokes were the main reasons for cognitive decline. So it actually protects the brain against atherosclerotic disease.
The Alzheimer disease is expected to rise over 100 million by 2050 and researchers from all over the world trying to find an effective treatment against the disease.
0 comments: